Ultrasound therapy developer ImaRx Therapeutics has closed a private placement for the issuance of 2.5 million shares of its common stock. The proceeds will be used to advance ImaRx's NanoInvasive surgery concept, which combines imaging, nanoparticles, and externally-applied energy to perform therapeutic procedures, according to the Tucson, AZ-based firm.
In other news, ImaRx has appointed John Moore as chairman. Moore is president and CEO of Edson Moore Healthcare Ventures (EMHV), which acquired an interest in ImaRx through its $150 million purchase of drug-delivery assets from biotechnology firm Elan.
By AuntMinnie.com staff writersApril 2, 2004
Related Reading
ImaRx inks licensing deal, November 19, 2003
Clinical trials begin for ImaRx, September 18, 2003
Ultrasound bubbles over into therapy, February 12, 2001
Copyright © 2004 AuntMinnie.com